VR-1065 is a serotonin 5-HT2C receptor agonist which was under development for the treatment of obesity but was never marketed. Its pharmacology has not been described.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.